Maeda H - Search Results

1

Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.

Tsuchiya K, Uchida T, Kobayashi M, Maeda H, Konno T, Yamanaka H. Tsuchiya K, et al. Among authors: maeda h. Urology. 2000 Apr;55(4):495-500. doi: 10.1016/s0090-4295(99)00537-3. Urology. 2000. PMID: 10736490

2

Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma.

Kobayashi M, Imai K, Sugihara S, Maeda H, Konno T, Yamanaka H. Kobayashi M, et al. Among authors: maeda h. Urology. 1991 Mar;37(3):288-94. doi: 10.1016/0090-4295(91)80308-t. Urology. 1991. PMID: 1848030

3

Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.

Kimoto A, Konno T, Kawaguchi T, Miyauchi Y, Maeda H. Kimoto A, et al. Among authors: maeda h. Cancer Res. 1992 Feb 15;52(4):1013-7. Cancer Res. 1992. PMID: 1531320

4

Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.

Kimura M, Konno T, Miyamoto Y, Kojima Y, Maeda H. Kimura M, et al. Among authors: maeda h. Anticancer Res. 1998 Jul-Aug;18(4A):2547-50. Anticancer Res. 1998. PMID: 9703908

5

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

Maeda H, Sawa T, Konno T. Maeda H, et al. J Control Release. 2001 Jul 6;74(1-3):47-61. doi: 10.1016/s0168-3659(01)00309-1. J Control Release. 2001. PMID: 11489482 Review.

6

[Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].

Maeda H, Konno T, Iwai K, Maki S, Tashiro S. Maeda H, et al. Gan To Kagaku Ryoho. 1984 Apr;11(4):814-26. Gan To Kagaku Ryoho. 1984. PMID: 6326681 Japanese.

7

Targeted vinblastine chemotherapy with two preparations of lipiodol contrast medium.

Oda T, Konno T, Nagamitsu A, Tabaru K, Maeda H, Kitamura N. Oda T, et al. Among authors: maeda h. Anticancer Res. 1997 Sep-Oct;17(5A):3521-9. Anticancer Res. 1997. PMID: 9413197

8

[Histological effect of SMANCS/LPD therapy in renal cell carcinoma].

Suzuki T, Kobayashi M, Nakamura T, Takahashi O, Imai K, Yamanaka H, Suzuki K, Konno T, Maeda H. Suzuki T, et al. Among authors: maeda h. Nihon Gan Chiryo Gakkai Shi. 1987 Oct 20;22(9):2210-7. Nihon Gan Chiryo Gakkai Shi. 1987. PMID: 2833546 Japanese. No abstract available.

9

[Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].

Konno T, Maeda H. Konno T, et al. Among authors: maeda h. Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):1043-50. Gan To Kagaku Ryoho. 1988. PMID: 2839112 Review. Japanese.

10

[Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].

Maeda H, Konno T. Maeda H, et al. Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 2):773-82. Gan To Kagaku Ryoho. 1985. PMID: 2985005 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,039 results

Search Page

Filters